Lancet Psychiatry recently published the results of a high-profile trial of cognitive behavior therapy as a treatment for so-called dissociative seizures, also known as psychogenic non-epileptic seizures. The trial, nicknamed…
…syndrome: Long term follow up and cost-effectiveness following the GETSET trial.” Professor Peter White, a member of the journal’s advisory board, is the senior author. In this clinical trial, the investigators…
…of functional neurological disorder (FND). In an impressive display of dishonesty, the press release from the lead university—King’s College London—touted the trial as a success. The release buried the bad…
…and/or updated it sooner. Dr Villemarette-Pittman had responded on behalf of the journal to my initial e-mail about the error, so I assumed she understood the practices and policies around…
…April crowdfunding on Berkeley’s in-house platform. The university received 1025 donations totally $103,283 for “Trial By Error.” Of those donations, the most–384–came from the UK. That was more than twice…
…into ME, CFS, so-called “medically unexplained symptoms,” etc., conducted under the “Trial By Error” name on Virology Blog, is my project as a UC Berkeley public health academic researcher and…
